Clinical Trials Directory

Trials / Completed

CompletedNCT01957020

Stereotactic Directional Vacuum-Assisted Breast Biopsy

The Diagnostic Accuracy of Stereotactic Directional Vacuum-Assisted Breast Biopsy

Status
Completed
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
Female
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

Stereotactic directional vacuum-assisted breast biopsy (ST DVAB) is a standard biopsy procedure for suspicious findings on mammograms in Western countries for more than 10 years \[1-3\], it has replaced the needle localization (NLOC) excisional biopsy for the lesions alike and was reported to feature a high sensitivity, very low delayed false-negative rate (less than 2%)\[4,5\]. Moreover, it causes less scarring, less psychologic stress to patients and less morbidity compared with needle localization excisional biopsy \[6,7\]. However, its sensitivity, accuracy has seldom been reported in Asian countries \[8\] , since most Asian women have different breast parenchyma pattern, different breast cancer prevalence. Therefore, we retrospectively reviewed outcomes of the two groups of patients receiving either ST DVAB or NLOC excisional biopsy, trying to investigate if ST DVAB can be an effective alternative to NLOC excisional biopsy in our country.

Conditions

Timeline

Start date
2008-06-01
Primary completion
2008-12-01
Completion
2009-01-01
First posted
2013-10-08
Last updated
2013-10-16

Source: ClinicalTrials.gov record NCT01957020. Inclusion in this directory is not an endorsement.